Cogstate Limited Stock Performance
| COGZF Stock | USD 0.64 0.03 4.48% |
Cogstate has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Cogstate are expected to decrease at a much lower rate. During the bear market, Cogstate is likely to outperform the market. Cogstate Limited right now shows a risk of 2.17%. Please confirm Cogstate Limited total risk alpha, as well as the relationship between the kurtosis and price action indicator , to decide if Cogstate Limited will be following its price patterns.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cogstate Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Cogstate may actually be approaching a critical reversion point that can send shares even higher in January 2025. ...more
| Begin Period Cash Flow | 23.6 M | |
| Total Cashflows From Investing Activities | -3.5 M |
Cogstate |
Cogstate Relative Risk vs. Return Landscape
If you would invest 58.00 in Cogstate Limited on September 4, 2024 and sell it today you would earn a total of 6.00 from holding Cogstate Limited or generate 10.34% return on investment over 90 days. Cogstate Limited is currently producing 0.1773% returns and takes up 2.1701% volatility of returns over 90 trading days. Put another way, 19% of traded otc stocks are less volatile than Cogstate, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cogstate Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cogstate's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Cogstate Limited, and traders can use it to determine the average amount a Cogstate's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0817
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | COGZF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.17 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Cogstate is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cogstate by adding it to a well-diversified portfolio.
Cogstate Fundamentals Growth
Cogstate OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Cogstate, and Cogstate fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cogstate OTC Stock performance.
| Return On Equity | 0.27 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.24 % | |||
| Current Valuation | 164.73 M | |||
| Shares Outstanding | 173.46 M | |||
| Price To Earning | 216.67 X | |||
| Price To Book | 6.27 X | |||
| Price To Sales | 4.76 X | |||
| Revenue | 44.98 M | |||
| EBITDA | 13.11 M | |||
| Cash And Equivalents | 30.6 M | |||
| Cash Per Share | 0.18 X | |||
| Total Debt | 1.41 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.19 X | |||
| Cash Flow From Operations | 9.73 M | |||
| Earnings Per Share | 0.04 X | |||
| Total Asset | 58.45 M | |||
| Retained Earnings | (15 M) | |||
| Current Asset | 14 M | |||
| Current Liabilities | 5 M | |||
About Cogstate Performance
By analyzing Cogstate's fundamental ratios, stakeholders can gain valuable insights into Cogstate's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cogstate has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cogstate has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia. Cogstate operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 380 people.Things to note about Cogstate Limited performance evaluation
Checking the ongoing alerts about Cogstate for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Cogstate Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cogstate Limited has some characteristics of a very speculative penny stock | |
| About 43.0% of the company shares are held by company insiders |
- Analyzing Cogstate's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cogstate's stock is overvalued or undervalued compared to its peers.
- Examining Cogstate's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cogstate's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cogstate's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Cogstate's otc stock. These opinions can provide insight into Cogstate's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cogstate OTC Stock analysis
When running Cogstate's price analysis, check to measure Cogstate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogstate is operating at the current time. Most of Cogstate's value examination focuses on studying past and present price action to predict the probability of Cogstate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogstate's price. Additionally, you may evaluate how the addition of Cogstate to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |